• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD PTA BALLOON DILATATION CATHETER CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD PTA BALLOON DILATATION CATHETER CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Catalog Number ATG120164
Device Problems Detachment of Device or Device Component (2907); Device Dislodged or Dislocated (2923); Unintended Movement (3026)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/25/2017
Event Type  malfunction  
Manufacturer Narrative
The device history records were reviewed with special attention to the raw materials, subassemblies, manufacturing process and quality control testing. This lot met all release criteria. There was nothing found to indicate there was a manufacturing related cause for this event. The device and two electronic photos were returned. A visual inspection found the entire balloon to be detached from the catheter. Therefore, the investigation is confirmed for the reported balloon detachment. Additionally, the investigation is confirmed for dislodged marker bands, as both marker bands were found to have dislodged on the inner guidewire lumen. However, the investigation is inconclusive for the reported movement of the device at the lesion site, due to the damaged balloon and as the conditions of use could not be recreated. The definitive root cause for the reported or identified issues could not be determined based upon available information. It is unknown whether procedural issues contributed to the event. Two electronic photos were reviewed. The first photo shows the device coiled on a blue background. What appears to be bloody balloon material is laying on the surface adjacent to the coiled device; the dislodged marker bands can be seen at the distal end of the inner guidewire lumen. The second photo shows the user holding the balloon material. Based on the photos reviewed, the reported balloon detachment can be confirmed. Dislodgment of the marker bands can also be confirmed. The current ifu (instructions for use) states: warnings: when the catheter is exposed to the vascular system, it should be manipulated while under high quality fluoroscopic observation. Do not advance or retract the catheter unless the balloon is fully deflated. If resistance is met during manipulation, determine the cause of the resistance before proceeding. Applying excessive force to the catheter can result in tip breakage or balloon separation. Do not exceed the rbp recommended for this device. Balloon rupture may occur if the rbp rating is exceeded. To prevent over pressurization, use of a pressure monitoring device is recommended. Precautions: if resistance is felt during post procedure withdrawal of the catheter through the introducer sheath, determine if contrast is trapped in the balloon with fluoroscopy. If contrast is present, push the balloon out of the sheath and then completely evacuate the contrast before proceeding to withdraw the balloon. If resistance is still felt during post procedure withdrawal of the catheter, it is recommended to remove the balloon catheter and guidewire/introducer sheath as a single unit. Use of the atlas gold pta dilation catheter: apply negative pressure to fully evacuate fluid from the balloon. Confirm that the balloon is fully deflated under fluoroscopy. While maintaining negative pressure and the position of the guidewire, withdraw the deflated dilatation catheter over-the-wire through the introducer sheath. Use of a gentle clockwise motion may be used to help facilitate catheter removal through the introducer sheath. (b)(4).
 
Event Description
It was reported that during an angioplasty procedure in the iliac vein, the pta balloon allegedly slipped at the lesion site and then detached from the catheter shaft. It was further reported that the health care provider (hcp) used a snare device to retrieve the detached balloon segment. The balloon was exchanged over the guidewire for another that was used to complete the procedure. There was no patient injury reported.
 
Manufacturer Narrative
No hospital/medical records have been made available to the manufacturer. However, photos of the balloon segment were provided for evaluation. As the lot number for the device was provided, a review of the device history records is currently being performed. The device has been returned to the manufacturer for evaluation. The investigation of the reported event is currently underway. The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during an angioplasty procedure in the iliac vein, the pta balloon allegedly detached from the catheter shaft. It was further reported that the health care provider (hcp) used a snare device to retrieve the detached balloon segment. The balloon was exchanged over the guidewire for another that was used during the procedure; however the second balloon allegedly inverted itself and partially detached from the catheter. There was no patient injury reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameATLAS GOLD PTA BALLOON DILATATION CATHETER
Type of DeviceCATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
FUTUREMATRIX INTERVENTIONAL
1605 enterprise street
athens TX 75751
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key6817160
MDR Text Key249018361
Report Number2020394-2017-01012
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K122984
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Reporter Occupation
Type of Report Initial,Followup
Report Date 10/23/2017
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received08/24/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date06/23/2020
Device Catalogue NumberATG120164
Device Lot Number93TB0159
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/08/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received10/12/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/23/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

-
-